SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-307348
Filing Date
2022-12-16
Accepted
2022-12-16 16:16:09
Documents
19
Period of Report
2022-12-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d407691d8k.htm   iXBRL 8-K 30461
2 EX-1.1 d407691dex11.htm EX-1.1 234021
3 EX-5.1 d407691dex51.htm EX-5.1 13002
4 EX-99.1 d407691dex991.htm EX-99.1 9207
5 EX-99.2 d407691dex992.htm EX-99.2 9598
9 GRAPHIC g407691g1216073933258.jpg GRAPHIC 2227
10 GRAPHIC g407691g1216073933508.jpg GRAPHIC 1705
11 GRAPHIC g407691g1216112325583.jpg GRAPHIC 4943
  Complete submission text file 0001193125-22-307348.txt   508951

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rna-20221215.xsd EX-101.SCH 2881
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20221215_lab.xml EX-101.LAB 17995
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20221215_pre.xml EX-101.PRE 11283
13 EXTRACTED XBRL INSTANCE DOCUMENT d407691d8k_htm.xml XML 3361
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 221468156
SIC: 2834 Pharmaceutical Preparations